Brief: NeurAxis Signs Exclusive Option Agreement with University of Michigan for Innovative Gastrointestinal Device
08/11/2023 14:14
Nov 8 (Reuters) - Neuraxis Inc NRXS.A :
* NEURAXIS SIGNS EXCLUSIVE OPTION AGREEMENT WITH UNIVERSITY
OF
MICHIGAN FOR INNOVATIVE GASTROINTESTINAL DEVICE
Source text for Eikon: ID:nGNX9fVpKK
Further company coverage: NRXS.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Neuraxis
See all newsBrief: Neuraxis Inc Expects Net Sales Of About $1.6 Million For Three Months Ended March 31, 2026
Brief: Neuraxis Reports Strong Fourth Quarter And Full Year 2025 Financial Results
Brief: Neuraxis Secures Veterans Affairs Federal Supply Schedule Contract, Broadening Access To More Patients With Functional Abdominal Pain
Brief: Neuraxis Wins First FDA Nod for FD Pain Treatment
Brief: Neuraxis Terminates License Agreement With Masimo